Here is what you need to know on Wednesday, June 30:
Well, we made it through June, statistically the worst performing period for equities and so far so good. One more day for bears to spoil it then. Delta is giving bears some room thought, the covid variant not the options greek. Europe is already under a new wave and reopenings have been pushed back in several EU countries. It is unclear if this new delta strain is more deadly but it is considerably more contagious than the alpha variant which was 60% more contagious than the original strain. All this is bound to put a strain on equity markets, especially with the Nasdaq putting its RSI into overbought territory. With the latest record rally the writing may be on the chart, below!
The US meanwhile powers on as the latest jobs report adds to the positive slew of recent data (ignoring inflation). ADP Employment came in at 692k jobs added versus 600k expected. Finally, the US is managing to hire but what is more important is if employers had to pay up to get those workers, time will tell.
The dollar remains quiet at 1.1880 versus the euro, Gold is lower at $1,757, Oil up at $74 (WTI) and Bitcoin is lower at $34,600. VIX has increased to just under 17 now so keep an eye. The 10-year yield is lower at 1.45%, a virtual nonfactor now the Fed has done such a good job!
European markets are all lower, Dax -0.7%, FTSE -0.4%, and EuroStoxx -0.6%.
US futures are flat, all flat no change, back to summer mode.
Wall street top news
Punchbowl reports that less than 10 Senate Republicans are backing President Biden's infrastructure bill.
US ADP employment 692k versus 600k.
Fed's Bostic says long-term inflation predictions from business are unchanged.
Bank of England's Haldane says uncomfortable with its balance sheet near £1 trillion.
Virgin Galactic (SPCE) Bank of America downgrades to underperform, shares down 5% premarket.
Bed Bath and Beyond (BBBY) misses on EPS but beats on revenue and raises outlook, shares up 7% premarket.
Atea Pharma (AVIR) up 11% premarket on Phase 2 trial results in covid 19 treatment.
Cerevel Thera (CERE) announces offering of 14 million shares, stock down 6% premarket.
MongoDB (MDB) announces upsized stock offering, shares down 5% premarket.
Intellia Thera (NTLA) announces capital raised of $600m at $145 per share. Stock up 1% premarket.
AppLovin (APP) today's award for best name! but Morgan Stanley downgrades, stock drops 3% premarket.
Xpeng (XPEV) to raise $1.8 billion in Hong Kong IPO according to sources cited by a CNBC report. Shares down 3% premarket.
Constellation Brands (STZ) EPS $2.33 in line with forecasts. Up 1.3% premarket.
PLUG Power, RBC starts coverage with an outperform, shares up 2% premarket.
General Mills (GIS) EPS of $0.91 versus forecasts for $0.84. Shares down 1.6% premarket.
DR Horton (DHI) named as a top pick by Goldman Sachs. Shares flat premarket.
Upgrades, downgrades, premarket movers
Source: Benzinga Pro
Economic releases
Like this article? Help us with some feedback by answering this survey:
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD clings to gains above 1.0750 after US data
EUR/USD manages to hold in positive territory above 1.0750 despite retreating from the fresh multi-week high it set above 1.0800 earlier in the day. The US Dollar struggles to find demand following the weaker-than-expected NFP data.
GBP/USD declines below 1.2550 following NFP-inspired upsurge
GBP/USD struggles to preserve its bullish momentum and trades below 1.2550 in the American session. Earlier in the day, the disappointing April jobs report from the US triggered a USD selloff and allowed the pair to reach multi-week highs above 1.2600.
Gold struggles to hold above $2,300 despite falling US yields
Gold stays on the back foot below $2,300 in the American session on Friday. The benchmark 10-year US Treasury bond yield stays in negative territory below 4.6% after weak US data but the improving risk mood doesn't allow XAU/USD to gain traction.
Bitcoin Weekly Forecast: Should you buy BTC here? Premium
Bitcoin (BTC) price shows signs of a potential reversal but lacks confirmation, which has divided the investor community into two – those who are buying the dips and those who are expecting a further correction.
Week ahead – BoE and RBA decisions headline a calm week
Bank of England meets on Thursday, unlikely to signal rate cuts. Reserve Bank of Australia could maintain a higher-for-longer stance. Elsewhere, Bank of Japan releases summary of opinions.